Last reviewed · How we verify
NCT04215185: BPI
Data Collection of BP Values by CS6BP
NA trial testing Arterial LIne in Blood Pressure in 80 participants. Status unknown.
15 June 2022
Quick facts
| Lead sponsor | CardiacSense Ltd. |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 80 |
| Start date | 3 July 2020 |
| Primary completion | 15 June 2022 |
| Estimated completion | 15 June 2022 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Arterial LIne
Conditions studied
- Blood Pressure — all drugs for Blood Pressure →
Sponsor
CardiacSense Ltd.
Who can join
18 and older, any sex, with Blood Pressure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this research is to collect data to develop an algorithm for continuous, non-inflating measurement of absolute, long-term Blood Pressure using the CS6BP device and to evaluate the safety of the CS6BP.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04215185
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Pressure
Currently open trials in the same condition.
- NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
- NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
- NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
- NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
- NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting
Other CardiacSense Ltd. trials
Trials by the same sponsor.
- NCT05591157 — Evaluation of CSF-3 in Performing ECG · NA · completed
- NCT05322382 — Accuracy of Pulse Oximeters With Profound Hypoxia · NA · completed
- NCT05370066 — Anonymized Data Collection From the CS6BP and Other Modalities for the Purpose Measurement of Blood Pressure · NA · unknown
- NCT05723744 — Anonymized Data Collection From the CS6BP for Heart Arrythmias Measurements · NA · completed
- NCT04580615 — Data Collection From the CardiacSense1 and Other Modalities for Developing a System for Monitoring of Respiratory Rate · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04215185 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CardiacSense Ltd.
- Last refreshed: 19 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04215185.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing